Conference Details - Agenda

Continuing Education Information

Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource designates this educational activity for a maximum of 23.25 AMA PRA Category 1 Credits™ (up to 17.25 for the main conference, 5 for the Minisymposium, and 1 for the Poster Viewing session). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.

27th Annual Miami Breast Cancer Conference™

Fontainebleau Miami Beach Hotel
Miami, FL
March 3-6, 2010

Wednesday, Mar 3, 2010

11:45 am-12:45 pm	Lunch on Own
Minisymposium
12:50 pm	Welcome Daniel A. Osman
Prevention Strategies
1:00 pm	Identifying the High-Risk Patient Debu Tripathy
1:15 pm	Breast Imaging Techniques to Screen High-Risk Patients Elizabeth Morris
1:30 pm	Chemoprevention in the High-Risk Patient V. Craig Jordan
1:45 pm	Surgical Management of the High-Risk Patient Benjamin Anderson
2:00 pm	Management of Patients With BRCA Mutations Patrick I. Borgen
Special Topics in the Management of Breast Cancer
2:15 pm	Special Histologic Types of Breast Cancer Underpinned by Genetic Aberration Jorge Reis-Filho
2:30 pm	Phyllodes Tumor Rache Simmons
2:45 pm	Paget Disease Thomas Julian
3:00 pm	Break
3:45 pm	Update on Cryotherapy Ablation Rache Simmons
4:00 pm	The Best of San Antonio and ASCO Hyman B. Muss
4:30 pm	Breast Health Global Initiative: Why It Matters to All of Us Benjamin Anderson
5:00 pm	Panel Discussion Moderator: Robert DerHagopian
5:15 pm	Special Guest Lecture Health Care Reform: What It Means to You and Your Patients Question-and-Answer Session Olveen Carrasquillo
6:30 pm	Adjourn
7:00 pm	Reception and Poster Viewing

Thursday, Mar 4, 2010

6:50 am-7:50 am	Breakfast in the Exhibit Hall
Transition From Borderline Lesions to DCIS – Invasive Breast Cancer
7:50 am	Welcome Daniel A. Osman
8:00 am	Different Genetic Pathways in the Development of Low-, Intermediate-, and High-Grade Ductal Cancer Jeffrey S. Ross
8:15 am	Defining the Spectrum From Indolent to Aggressive DCIS: Markers of Tumor Invasion and Metastasis Lance Liotta
8:30 am	Role of the Stroma and Microenvironment in Breast Cancer Progression Lance Liotta
8:45 am	What Are the Clinical Implications of Breast Cancer Stem Cells? Umberto Veronesi
9:00 am	New Therapeutic Approaches to Early Breast Cancer Stefano Zurrida
9:15 am	The Role of MRI in the Pretreatment Evaluation of Patients With Biopsy-Proven Malignancy Abram Recht
9:30 am	Controversies of MRI Staging and Its Impact on Surgery and Outcomes Elizabeth Morris
9:45 am	The Rationale for a Change in Classification of Breast Cancer Umberto Veronesi
10:00 am	Break
Options in Radiation Therapy
10:45 am	Accelerated Partial-Breast Irradiation: Indications and Timing Douglas Arthur
11:00 am	Intensity-Modulated Radiation Therapy Abram Recht
11:15 am	Shorter Fractionation Schedule: Clinical and Economic Implications John R. Yarnold
11:30 am	Intraoperative vs. Whole-Breast Irradiation Mattia Intra
11:45 am	Can Radiation Therapy Be Omitted in Some Invasive Breast Cancer? Abram Recht
12:00 pm	Panel Discussion Moderator: Robert DerHagopian
12:45 pm	Hands-On Workshops (Space Limited) or Lunch on Own
Session A: Ipsilateral Breast Cancer Recurrence Moderator – J. Michael Dixon
2:00 pm	Influence of Volume of Disease at Margin and Risk of Local Recurrence in DCIS: What Is an Adequate Margin? Kimberly J. Van Zee
2:15 pm	Breast-Conserving Options Following Local Recurrence Douglas Arthur
2:30 pm	Prognosis and Management of Local Recurrence After Mastectomy Thomas Julian
2:45 pm	Effect of Breast Duct Anatomy and “Wound-Healing Response” on Local Recurrence John R. Yarnold
3:00 pm	Panel Discussion Moderator: J. Michael Dixon
Sentinel Nodes
3:30 pm	Selection of Patients for Axillary Node Dissection in the Sentinel Node Era Mattia Intra
3:45 pm	Nomograms and the Risk of Additional Non–Sentinel Node Metastases Kimberly J. Van Zee
4:00 pm	Break
4:30 pm	Outcomes Following Positive Sentinel Node Biopsy With or Without Axillary Dissection Thomas Julian
4:45 pm	When and How Should We Intervene in the Axilla After a Previous Sentinel Node Biopsy? Stefano Zurrida
5:00 pm	Intraoperative Evaluation of Sentinel Nodes Jeffrey S. Ross
5:15 pm	Axillary Surgery: Can We Distinguish Between Breast and Arm Nodes? Krishna B. Clough
5:30 pm	Internal Mammary Nodes: Ignore/Irradiate/Dissect? Umberto Veronesi
5:45 pm	Adjourn
5:45 pm-6:30 pm	Meet the Professors: Benjamin Anderson, Patrick I. Borgen, Mattia Intra, Thomas Julian, Rache Simmons
Session B: Clinical Implications of Breast Cancer Phenotypes Moderator – Debu Tripathy
2:00 pm	The Biology of Triple-Negative Tumors Charles Perou
2:15 pm	Is Triple-Negative and Basal-like Breast Cancer the Same? Jorge Reis-Filho
2:30 pm	Emerging Therapies for Triple-Negative Tumors Joyce O’Shaughnessy
2:45 pm	The Role of Androgen Receptor in Triple-Negative Tumors Clifford Hudis
3:00 pm	Insulin-like Growth Factor: A New Target for Therapy Marc Lippman
3:15 pm	When Should Gene Profiling Be Used to Determine Therapy in Patients With Node-Negative and Node-Positive Disease? Harold Burstein
3:30 pm	Management of HER2-Positive Node-Negative Tumors Measuring Less Than 1 cm Joyce O’Shaughnessy
3:45 pm	Circulating and Disseminated Tumor Cells: Prognostic and Predictive Implications Jeffrey S. Ross
4:00 pm	Break
4:30 pm	The Role of Maintenance Therapy for Metastatic Breast Cancer Debu Tripathy
4:45 pm	Case-Based Panel Discussion Moderator: Debu Tripathy
5:45 pm	Adjourn
5:45 pm-6:30 pm	Meet the Professors: Harold Burstein, Jorge Reis-Filho, Jeffrey S. Ross, Debu Tripathy
6:15 pm-7:30 pm	“Get Acquainted” Reception

Friday, Mar 5, 2010

6:50 am-7:50 am	Breakfast in the Exhibit Hall
Personalizing Decision Making Based on Biomarkers
8:00 am	Use of Genomic Assays in Guiding Systemic Therapy William J. Gradishar
8:15 am	What Can We Learn From Proteomics? Lance Liotta
8:30 am	How Novel Targets Have Identified New Agents Now Being Tested in Clinical Trials Jorge Reis-Filho
8:45 am	Hormonal Therapy for Breast Cancer: The Latest in Therapy and Prognostic Assays Harold Burstein
9:00 am	Integrating Pharmacogenomics Into Clinical Practice Jeffrey S. Ross
Strategies to Overcome Tumor Resistance Moderator – Marc Lippman
9:15 am	Targeting Tumor Hypoxia Charles Perou
9:25 am	Mechanisms of Resistance to Antiangiogenic Agents Kathy D. Miller
9:35 am	Proteomics: A Tool to Investigate Drug Resistance Lance Liotta
9:45 am	Panel Discussion Moderator: Marc Lippman
10:05 am	Break
10:50 am	Are We Hitting the Right Combination for Hormonally Sensitive Breast Cancer? Debu Tripathy
11:00 am	Strategies for Patients With Refractory HER2-Positive Breast Cancer Eric P. Winer
11:10 am	The Role of Heat Shock Protein 90 Inhibition Clifford Hudis
11:20 am	Panel Discussion Moderator: Marc Lippman
11:40 am	New Chemotherapy Formulations to Overcome Drug Resistance William J. Gradishar
11:50 am	Novel Antimicrotubule Agents Edith A. Perez
12:00 pm	DNA Damage Response as a Cause of Drug Resistance Jorge Reis-Filho
12:10 pm	Panel Discussion Moderator: Marc Lippman
12:30 pm	Hands-On Workshops (Space Limited) or Lunch on Own
Session A: Oncoplastic Surgery Moderator – J. Michael Dixon
2:00 pm	Nipple-Sparing Mastectomy for Prophylaxis and Other Indications Patrick I. Borgen
2:15 pm	Techniques to Minimize Reexcision Rates and Deformities Krishna B. Clough
2:30 pm	Avoiding Mastectomy in Patients With Multifocal Cancers and Extensive DCIS J. Michael Dixon
2:45 pm	Lipofilling to Improve Cosmetic Results After Breast-Conserving Surgery Emmanuel Delay
3:00 pm	Minimally Invasive Autologous Fat Reconstruction Technique Roger K. Khouri
3:15 pm	Breast Implant Reconstruction With the Use of Collagen Matrix J. Michael Dixon
3:30 pm	Extended Latissimus Dorsi Flap and Reconstruction Emmanuel Delay
3:45 pm	Mammoplastic Techniques to Extend Breast Conservation Possibilities Krishna B. Clough
4:00 pm	Panel Discussion Moderator: J. Michael Dixon
4:30 pm	Break
5:00 pm-5:45 pm	Meet the Professors: Krishna B. Clough, Emmanuel Delay, Roger K. Khouri
Session B: Emerging and Controversial Topics in Systemic Adjuvant Therapy Moderator – Debu Tripathy
2:00 pm	What Is the Role of Ovarian Suppression in Premenopausal Patients? Harold Burstein
2:15 pm	Predictors of Permanent Menopause After Chemotherapy V. Craig Jordan
2:30 pm	Addressing Menopausal Symptoms and Fertility in Breast Cancer Eric P. Winer
2:45 pm	Adjuvant Chemotherapy in Older Women Hyman B. Muss
3:00 pm	The Latest on Bone-Directed Therapy for Breast Cancer Edith A. Perez
3:15 pm	Choosing the Optimal Adjuvant Chemotherapy Regimen, Dose, and Schedule Clifford Hudis
3:30 pm	Defining the Benefit of Antiangiogenic Therapy in Specific Settings and Combinations Kathy D. Miller
3:45 pm	Gene Expression Signatures to Identify Responders/ Nonresponders to Therapy: New Insights and Strategies Charles Perou
4:00 pm	Panel Discussion Moderator: Debu Tripathy
4:30 pm	Break
5:00 pm-5:45 pm	Meet the Professors: William J. Gradishar, Clifford Hudis, Kathy D. Miller, Hyman B. Muss, Edith A. Perez, Charles Perou, Eric P. Winer
6:30 pm-8:00 pm	Gala Reception

Related Materials

Conference Lectures

26th Annual Miami Breast Cancer Conference
Day 4 Main Conference
Mar 7, 2009 26th Annual Miami Breast Cancer Conference
Day 3 Main Conference
Mar 6, 2009 26th Annual Miami Breast Cancer Conference
Day 2 Main Conference
Mar 5, 2009 26th Annual Miami Breast Cancer Conference
Day 1 Minisymposium
Mar 4, 2009

Educational Grants

An educational grant for this activity was provided by:

Educational Partners
Genentech BioOncology
Major Contributors
Novartis Oncology
sanofi-aventis U.S.
Supporters
Bristol-Myers Squibb
Eisai, Inc.
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Honorary Supporter
Joe’s Stone Crab Restaurant

WHAT'S NEW

VIEW ALL

ARCHIVE

DISEASE

TOPIC

CONFERENCE TYPE

LOCATION

WHAT'S NEW

VIEW ALL

MULTIACTIVITY LEARNING

DISEASE

TOPIC

ACTIVITY TYPE

Conference Details - Agenda

Continuing Education Information

Wednesday, Mar 3, 2010

Thursday, Mar 4, 2010

Friday, Mar 5, 2010

Saturday, Mar 6, 2010

Related Materials

Conference Lectures

Educational Grants

WHAT'S NEW

Contact PER

6:50 am-7:50 am	Breakfast in the Exhibit Hall
Future Challenges
8:00 am	Challenges to Improve Adjuvant Endocrine Therapy V. Craig Jordan
8:15 am	Vaccine Strategies for HER2-Positive Cancer Edith A. Perez
Challenges in Treatment and Follow-Up
8:30 am	New Breast Imaging Techniques in Breast Cancer Screening Patrick I. Borgen
8:45 am	Technique and Impact of Nodal Irradiation on the Risk of Lymphedema Abram Recht
9:00 am	Predictive Markers of Response to Preoperative Therapy: Does It Affect Decision Making? Kathy D. Miller
9:15 am	Monitoring Response to Preoperative Therapy Elizabeth Morris
9:30 am	Long-Term Surveillance and Care for Breast Cancer Survivors William J. Gradishar
9:45 am	The Role of Integrative or Complementary/Alternative Medicine Debu Tripathy
10:00 am	Break
10:45 am	The Role of the Surgeon in Translational Research J. Michael Dixon
11:00 am	Problems in the Diagnosis of Breast Cancer: Lessons Learned and How to Avoid Them J. Michael Dixon
11:15 am	Panel Discussion Moderator: Robert DerHagopian
12:00 pm	Adjourn